Standout Papers

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Res... 2012 2026 2016 2021 1.2k
  1. A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression (2012)
    Charles L. Raison, Robin E. Rutherford et al. JAMA Psychiatry

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 159 standout
Sub-graph 1 of 19

Citing Papers

Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
32 intermediate papers

Works of Daniel Drake being referenced

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
2012 Standout
Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression
2008
and 2 more

Author Peers

Author Last Decade Papers Cites
Daniel Drake 1574 1137 487 21 2.3k
Nicole DellaGioia 1217 861 388 27 2.0k
Marisa Toups 925 606 260 21 1.9k
Yekta Dowlati 2535 1889 643 15 4.0k
Nilay Hepgul 1035 899 212 40 2.5k
David R. Goldsmith 2187 1301 495 52 3.4k
E. Suy 1895 1673 255 46 2.8k
Lauren Sham 2437 1779 625 8 3.6k
Donald M. Lamkin 1527 1244 289 26 3.2k
Vladimir Maletic 2190 1564 702 32 4.7k
Emanuele F. Osimo 1027 597 199 24 1.8k

All Works

Loading papers...

Rankless by CCL
2026